Aridis Pharmaceuticals (ARDS) Financials

$0.00

$-0.07 (-99.86%)

As on 04-Sep-2026 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$20 Mln

P/E Ratio

--

P/B Ratio

5.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	20.06	19.25	1.54	1.00	1.02	2.76
Cost of Revenue	--	--	--	--	--	23.00
Gross Profit	20.06	--	1.54	1.00	1.02	2.76
Operating Expenses	20.53	29.99	43.71	23.40	30.11	26.87
Operating Profit (EBIT)	-0.88	-29.99	-43.71	-22.40	-29.09	-24.12
Other Income	--	--	--	-0.01	-0.59	2.01
Profit before Tax	-1.14	-30.37	-43.19	-22.33	-29.68	-22.11
Provision for Tax	0.46	0.38	-0.91	-0.41	-0.70	2.43
Profit after Tax (Net Income)	-1.14	-30.75	-42.28	-22.33	-28.99	-22.11
Minority Interest	--	--	--	--	--	--
Consolidated Profit	36.43	--	-46.32	-22.33	-29.68	-23.46

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-11.80	-24.23	-13.11	-8.68	3.64	26.31
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.85	2.03	6.56	1.36	5.00	--
Current Liabilities	17.48	36.90	33.35	22.44	19.33	5.30
Total Liabilities	24.02	14.70	26.80	15.12	27.97	31.61

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	2.42	3.07	2.41	1.29	2.13	7.37
Current Assets	4.11	11.63	26.80	15.12	27.97	24.24
Total Assets	24.02	14.70	26.80	15.12	27.97	31.61
Total Debt*	4.84	6.13	5.98	0.72	--	--
Net Current Assets	-13.37	-25.27	-8.96	-9.69	6.51	23.05

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-29.13	-22.94	-20.48	-8.16	-24.27
Cash Flow from Investing Activities	--	-0.08	-0.53	-0.37	-0.17	-1.68
Cash from Financing Activities	--	14.78	34.72	8.68	4.99	25.09
Net Cash Inflow / Outflow	--	--	--	-12.17	-3.34	-0.86

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-0.13	-1.14	-2.92	-2.26	-3.25	-2.73
Cash EPS ($)	--	-1.12	-2.89	-2.22	-3.21	-2.69
Adjusted Book Value ($)	--	--	--	--	0.41	3.25
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.08	-1.58	-2.07	-0.92	-2.99
Free Cash Flow per Share ($)	--	-1.08	-1.62	-2.10	-0.93	-3.08

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	243.71	560.09	1,031.55	-193.56	-117.11
ROE (%)	--	164.69	388.06	885.35	-193.56	-117.11
ROA (%)	-2.91	-148.22	-201.76	-103.67	-97.30	-76.11
EBIT Margin (%)	-3.27	-155.81	-2,829.84	-2,233.30	-2,846.09	-874.76
Net Margin (%)	-5.69	-159.74	-2,754.46	-2,253.58	-6,772.43	-463.51
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	1,301.12	11.54	0.54	-0.02	-0.63	2.21
EBIT Growth (%)	97.89	30.95	-94.50	23.22	-20.61	-22.19
Net Profit Growth (%)	96.79	27.27	-89.32	22.95	-31.13	10.35
EPS Growth (%)	93.90	0.61	-0.29	0.31	-0.19	0.13
Book Value Growth (%)	84.42	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-1.04	-0.80	-2.69	-1.37	-4.07
Price / Book Value	5.40	-1.32	-2.58	-6.92	10.91	3.42
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.87	-1.12	-0.46	1.67	-0.65	-2.75
Close Price ($)	0.10	1.18	2.33	6.07	4.45	11.09
High Price ($)	1.75	2.94	8.47	10.18	12.40	13.85
Low Price ($)	0.05	0.68	1.89	3.80	4.07	7.59
Market Cap ($ Cr)	0.00	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	-0.25	-0.46	-0.08	--	--
Short term debt to equity ratio	-0.34	-0.20	-0.05	-0.05	--	0.09
Current Ratio	0.24	0.32	0.80	0.67	1.45	4.58
Quick Ratio	0.26	--	0.81	0.69	1.47	5.35
Interest Coverage	-35.84	-79.35	-177.30	--	--	-57.42

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	2.58	6.44	15.44	36.80	40.41	76.10
Asset Turnover	0.51	0.93	0.07	0.05	0.03	0.09
Receivable days	--	14.01	71.98	142.63	448.70	277.95
Inventory Days	--	--	--	--	--	-65.27
Payable days	--	--	--	--	--	25.92
Cash Conversion Cycle	--	--	--	--	--	186.76

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.